Federal Level Kathleen Otto 5/6/24 Kathleen Otto 5/6/24 Economic Downturns Boost Success for Startups Read More Kathleen Otto 5/2/24 Kathleen Otto 5/2/24 Apple Watch's AFib History Feature Enters FDA Program, Enabling Clinical Studies Read More Kathleen Otto 4/23/24 Kathleen Otto 4/23/24 NIH to increase pay levels for pre- and postdoctoral scholars at grantee institutions Read More Kathleen Otto 3/13/24 Kathleen Otto 3/13/24 Securing America's Biotech Leadership for National Security Read More Kathleen Otto 1/29/24 Kathleen Otto 1/29/24 Nurturing Trust in the Digital Age for Consumer Confidence Read More Kathleen Otto 1/19/24 Kathleen Otto 1/19/24 AI's Influence on Gene Therapy: Optimizing Development for Success Read More Kathleen Otto 1/19/24 Kathleen Otto 1/19/24 Proposed Inflation Reduction Act Expansion Threatens U.S. Biopharma with Job Losses and Innovation Decline Read More Kathleen Otto 1/18/24 Kathleen Otto 1/18/24 The Impact of The House Proposed IRA Expansion on the US Biopharma Ecosystem Read More Kathleen Otto 1/16/24 Kathleen Otto 1/16/24 Loss of Tax Incentive for R&D Threatens Biotech Innovation Read More Kathleen Otto 1/11/24 Kathleen Otto 1/11/24 Critical Path Institute Takes the Lead in Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases with New Task Force Read More Kathleen Otto 10/26/23 Kathleen Otto 10/26/23 ARPA-H Celebrates Official Launch of Investor Catalyst Hub Read More Kathleen Otto 9/26/23 Kathleen Otto 9/26/23 NIH BRAIN Initiative Launches Projects to Develop Innovative Technologies to Map the Brain Read More Kathleen Otto 8/23/23 Kathleen Otto 8/23/23 ARPA-H Launches the CUREIT project to Develop New Tools to Strengthen the Immune System and Save Lives Read More Kathleen Otto 8/15/23 Kathleen Otto 8/15/23 NORD Announces More Than $100,000 in Grant Funding Available for Rare Disease Research Read More Kathleen Otto 7/28/23 Kathleen Otto 7/28/23 What do you Know About the Inflation Reduction Act? Read More Kathleen Otto 7/26/23 Kathleen Otto 7/26/23 What’s Next for Biopharma Under the Inflation Reduction Act Read More Kathleen Otto 6/26/23 Kathleen Otto 6/26/23 Biden-Harris Administration Launches Initiative to Improve Cancer Outcomes in Low-Income Areas Read More Kathleen Otto 6/21/23 Kathleen Otto 6/21/23 Trends in the Approval of Cancer Therapies by the FDA in the 21st Century Read More Kathleen Otto 6/20/23 Kathleen Otto 6/20/23 FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers Read More Kathleen Otto 6/14/23 Kathleen Otto 6/14/23 Why Gene Therapies Must Go Virus-Free Read More Older Posts
Kathleen Otto 5/2/24 Kathleen Otto 5/2/24 Apple Watch's AFib History Feature Enters FDA Program, Enabling Clinical Studies Read More
Kathleen Otto 4/23/24 Kathleen Otto 4/23/24 NIH to increase pay levels for pre- and postdoctoral scholars at grantee institutions Read More
Kathleen Otto 3/13/24 Kathleen Otto 3/13/24 Securing America's Biotech Leadership for National Security Read More
Kathleen Otto 1/29/24 Kathleen Otto 1/29/24 Nurturing Trust in the Digital Age for Consumer Confidence Read More
Kathleen Otto 1/19/24 Kathleen Otto 1/19/24 AI's Influence on Gene Therapy: Optimizing Development for Success Read More
Kathleen Otto 1/19/24 Kathleen Otto 1/19/24 Proposed Inflation Reduction Act Expansion Threatens U.S. Biopharma with Job Losses and Innovation Decline Read More
Kathleen Otto 1/18/24 Kathleen Otto 1/18/24 The Impact of The House Proposed IRA Expansion on the US Biopharma Ecosystem Read More
Kathleen Otto 1/16/24 Kathleen Otto 1/16/24 Loss of Tax Incentive for R&D Threatens Biotech Innovation Read More
Kathleen Otto 1/11/24 Kathleen Otto 1/11/24 Critical Path Institute Takes the Lead in Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases with New Task Force Read More
Kathleen Otto 10/26/23 Kathleen Otto 10/26/23 ARPA-H Celebrates Official Launch of Investor Catalyst Hub Read More
Kathleen Otto 9/26/23 Kathleen Otto 9/26/23 NIH BRAIN Initiative Launches Projects to Develop Innovative Technologies to Map the Brain Read More
Kathleen Otto 8/23/23 Kathleen Otto 8/23/23 ARPA-H Launches the CUREIT project to Develop New Tools to Strengthen the Immune System and Save Lives Read More
Kathleen Otto 8/15/23 Kathleen Otto 8/15/23 NORD Announces More Than $100,000 in Grant Funding Available for Rare Disease Research Read More
Kathleen Otto 7/28/23 Kathleen Otto 7/28/23 What do you Know About the Inflation Reduction Act? Read More
Kathleen Otto 7/26/23 Kathleen Otto 7/26/23 What’s Next for Biopharma Under the Inflation Reduction Act Read More
Kathleen Otto 6/26/23 Kathleen Otto 6/26/23 Biden-Harris Administration Launches Initiative to Improve Cancer Outcomes in Low-Income Areas Read More
Kathleen Otto 6/21/23 Kathleen Otto 6/21/23 Trends in the Approval of Cancer Therapies by the FDA in the 21st Century Read More
Kathleen Otto 6/20/23 Kathleen Otto 6/20/23 FDA Launches Pilot Program to Help Reduce Risks Associated with Using Laboratory Developed Tests to Identify Cancer Biomarkers Read More
